These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8705995

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Modulatory effects of tamoxifen and recombinant human alpha-interferon on doxorubicin resistance.
    Kang Y, Perry RR.
    Cancer Res; 1993 Jul 01; 53(13):3040-5. PubMed ID: 8100483
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues.
    Chambers SK, Hait WN, Kacinski BM, Keyes SR, Handschumacher RE.
    Cancer Res; 1989 Nov 15; 49(22):6275-9. PubMed ID: 2804973
    [Abstract] [Full Text] [Related]

  • 6. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
    Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A.
    Clin Cancer Res; 2000 May 15; 6(5):1949-57. PubMed ID: 10815920
    [Abstract] [Full Text] [Related]

  • 7. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.
    Wong HL, Bendayan R, Rauth AM, Xue HY, Babakhanian K, Wu XY.
    J Pharmacol Exp Ther; 2006 Jun 15; 317(3):1372-81. PubMed ID: 16547167
    [Abstract] [Full Text] [Related]

  • 8. Modulation of doxorubicin resistance by valinomycin (NSC 122023) and liposomal valinomycin in Chinese hamster ovary cells.
    Daoud SS, Juliano RL.
    Cancer Res; 1989 May 15; 49(10):2661-7. PubMed ID: 2713850
    [Abstract] [Full Text] [Related]

  • 9. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
    Park SJ, Wu CH, Safa AR.
    Anticancer Res; 2004 May 15; 24(1):123-31. PubMed ID: 15015586
    [Abstract] [Full Text] [Related]

  • 10. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer.
    Alakhov VYu, Moskaleva EYu, Batrakova EV, Kabanov AV.
    Bioconjug Chem; 1996 May 15; 7(2):209-16. PubMed ID: 8983343
    [Abstract] [Full Text] [Related]

  • 11. Chemosensitizing activity of caffeic acid in multidrug-resistant MCF-7/Dox human breast carcinoma cells.
    Ahn CH, Choi WC, Kong JY.
    Anticancer Res; 1997 May 15; 17(3C):1913-7. PubMed ID: 9216644
    [Abstract] [Full Text] [Related]

  • 12. Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole.
    Desai PB, Duan J, Sridhar R, Damle BD.
    Methods Find Exp Clin Pharmacol; 1997 May 15; 19(4):231-9. PubMed ID: 9228648
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
    Ogretmen B, McCauley MD, Safa AR.
    Biochemistry; 1998 Aug 18; 37(33):11679-91. PubMed ID: 9709006
    [Abstract] [Full Text] [Related]

  • 16. The ability of selected pyridinium salts to increase the cytotoxic activity of vincristine but not doxorubicin towards sensitive and multidrug resistant promyelocytic leukaemia HL60 cells.
    Maruszewska A, Kostrzewa-Nowak D, Adamus J, Czupryńska K, Maryniak D, Gebicki J, Tarasiuk J.
    J Pharm Pharmacol; 2008 May 18; 60(5):647-53. PubMed ID: 18416942
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, characterization, antitumor activity of pluronic mimicking copolymer micelles conjugated with doxorubicin via acid-cleavable linkage.
    Lee Y, Park SY, Mok H, Park TG.
    Bioconjug Chem; 2008 Feb 18; 19(2):525-31. PubMed ID: 18163537
    [Abstract] [Full Text] [Related]

  • 18. Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism.
    Shen J, He Q, Gao Y, Shi J, Li Y.
    Nanoscale; 2011 Oct 05; 3(10):4314-22. PubMed ID: 21892492
    [Abstract] [Full Text] [Related]

  • 19. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C, Wellham LL.
    Anticancer Res; 2003 Oct 05; 23(3B):2681-90. PubMed ID: 12894558
    [Abstract] [Full Text] [Related]

  • 20. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y, Qian F, Wei D, Liu J.
    J Pharm Pharmacol; 2004 Oct 05; 56(10):1307-14. PubMed ID: 15482646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.